Johnson & Johnson vs Thermo Fisher Scientific, Inc.
JNJ vs TMO — side-by-side comparison from reported financials. JNJ leads 9, TMO leads 1 of 10 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Thermo Fisher Scientific, Inc.
TMO · Healthcare
$658.02+0.93%Mixed
| Metric | JNJ | TMO |
|---|---|---|
| Price | $261.79 | $658.02 |
| Market cap | $631B | $243B |
| Revenue (TTM) | $97.9B | $46.3B |
| Revenue growth | +5.6% | -0.3% |
| Net margin | 21.5% | 15.0% |
| Free cash flow | $22.2B | $7.32B |
| Net cash (debt) | ($27.8B) | ($29.3B) |
| 1-year price return | +37.0% | +23.1% |
| P/E | 29.9 | 34.9 |
| P/E vs own history (cheap-side %) | 16% | 24% |
| Dividend yield | 2.00% | 0.27% |
| Return on equity | 26% | 13% |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 140,800 | 125,000 |
Full résumé-style profiles: JNJ CV · TMO CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.